Acrivon Therapeutics, Inc. Liquidation Value
ACRV
Other
Cash & Equivalents
$41.50M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $41.50M
Total Obligations: -$18.37M
$23.13M
Per share: $0.73
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $41.50M
AR: $0
Total Obligations: -$18.37M
$23.13M
Per share: $0.73
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $41.50M
AR: $0
Inventory: $0
Total Obligations: -$18.37M
$23.13M
Per share: $0.73
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $23.13M | $0.73 |
| Liquid Liquidation Value | $23.13M | $0.73 |
| Operating Liquidation Value | $23.13M | $0.73 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $41.50M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $15.66M |
| Long-term Debt | N/A |
| Op. Lease Liability | $2.71M |
| Finance Lease | N/A |
| Shares Outstanding | 31.6M |
Explore all 146 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $41.50M | N/A | N/A | $2.28M | $15.66M | N/A | $2.71M | N/A |
| 2025-09-30 | $35.41M | N/A | N/A | $996,000 | $14.89M | N/A | $2.99M | N/A |
| 2025-06-30 | $41.90M | N/A | N/A | $1.16M | $13.43M | N/A | $3.26M | N/A |
| 2025-03-31 | $39.15M | N/A | N/A | $3.69M | $13.55M | N/A | $3.51M | N/A |
▼ Community Notes